Fluticasone Propionate
The EFFECT trial: evaluating exacerbations, biomarkers, and safety outcomes with two dose levels of fluticasone propionate/formoterol in COPD
8
Clinical and economic outcomes for patients initiating fluticasone propionate/salmeterol combination therapy (250/50 mcg) versus anticholinergics in a comorbid COPD/depression population
9
Efficacy of Low-Dose Ciclesonide and Fluticasone Propionate for Mild to Moderate Persistent Asthma
9
A review of the clinical efficacy and safety of MP-AzeFlu, a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate, in clinical studies conducted during different allergy seasons in the US
9
The lung function profile of once-daily tiotropium and olodaterol via Respimat<sup>®</sup> is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler<sup>®</sup> (ENERGITO<sup>®</sup> study)<div><br /></div>
13
Lost in the Mist: Acute Adrenal Crisis Following Intranasal Fluticasone Propionate Overuse
5
ANALYTICAL STABILITY INDICATING UPLC ASSAY AND VALIDATION OF FLUTICASONE PROPIONATE IN NASAL SPRAY INHALER DOSAGE FORM
5
Long-Term Safety of Fluticasone Propionate and Nedocromil Sodium on Bone in Children With Asthma
10
Development and Validation of Analytical Method for Simultaneous Estimation of Formoterol Fumarate Dihydrate and Fluticasone Propionate from Bulk and Dry Powder Inhaler Formulation
11
Umeclidinium/vilanterol versus fluticasone propionate/salmeterol in COPD: a randomised trial
12
Triple therapy with salmeterol/fluticasone propionate 50/250 plus tiotropium bromide improve lung function versus individual treatments in moderate-to-severe Japanese COPD patients: a randomized controlled trial – Evaluation of Airway sGaw after treatment with tripLE
12
Development and evaluation of novel Fluticasone Propionate Emulgel for topical drug delivery
9
The role of fluticasone propionate/salmeterol combination therapy in preventing exacerbations of COPD
14
Fluticasone propionate/formoterol for COPD management: a randomized controlled trial
11
DEVELOPMENT AND VALIDATION OF ULTRA PERFORMANCE LIQUID CHROMATOGRAPHIC METHOD FOR THE ANALYSIS OF PULMONARY DRUG PRODUCT CONTAINING FORMOTEROL FUMARATE AND FLUTICASONE PROPIONATE
6
Salmeterol plus fluticasone propionate versus fluticasone propionate plus montelukast: a randomised controlled trial investigating the effects on airway inflammation in asthma
7
Comparison of fluticasone propionate and budesonide on COPD macrophage and neutrophil function
15
Seasonal allergic rhinitis: fluticasone propionate and fluticasone furoate therapy evaluated
10
Fluticasone propionate-salmeterol versus inhaled corticosteroids plus montelukast: outcomes study in pediatric patients with asthma
10
Fluticasone Propionate Aqueous Nasal Spray Is Safe and Effective for Children With Seasonal Allergic Rhinitis
8